Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now indicates recruitment is closed and introduces new guidance sections for reading the study record and joining the study, along with a formatting change to the Intervention/Treatment heading and a revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check8 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation/metadata.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a newer patch level has been applied to the page metadata. It signals a minor update to the page's versioning metadata and change log rather than alterations to core content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer software revision was updated from **v3.5.2** to **v3.5.3** without any stated changes to the underlying study details.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.